Improving pregnancy outcomes for women with type 1 diabetes has long been the research interest of Professor Elisabeth Mathieson. Here, she discusses how far we’ve come in understanding the best insulin options and the results of the recent EXPECT trial comparing insulin degludec versus insulin detemir.